A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients with Perennial Allergic Rhinitis

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/038/31/05

Funding

  • Merck and Company Inc: $10,680.00